Healthcare -
Biotechnology - NASDAQ - NL
$ 39.45
-0.504 %
$ 2.7 B
Market Cap
-9.72
P/E
MRUS - STOCK-BASED COMPENSATION
Stock-based Compensation MRUS - Merus N.V.
26.2 M
LAST VALUE
23.87%
2 YEAR CAGR
23.67%
5 YEAR CAGR
59.17%
10 YEAR CAGR